Financials Aarti Drugs Limited

Equities

Market Closed - Bombay S.E. Other stock markets 03:30:47 18/07/2025 pm IST			5-day change	1st Jan Change
522.65 ^INR	+1.34%		+10.36%	+13.46%

18/07	Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
07/05	Aarti Drugs Consolidated Net Profit Jumps in Fiscal Q4	MT

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	18,061	21,548	24,886	27,160	25,286	23,870	26,883	30,271
Change	-	19.31%	15.49%	9.14%	-6.9%	-5.6%	12.62%	12.6%
EBITDA ¹	2,618	4,371	3,294	3,056	3,165	2,871	3,737	4,389
Change	-	66.95%	-24.63%	-7.24%	3.56%	-9.29%	30.18%	17.45%
EBIT ¹	-	3,872	2,794	2,553	2,650	2,313	3,123	3,721
Change	-	-	-27.85%	-8.63%	3.82%	-12.73%	35.03%	19.15%
Interest Paid ¹	-337.3	-229.6	-207.5	-332.9	-335.2	-358.7	-351	-343
Earnings before Tax (EBT) ¹	1,853	3,690	2,700	2,242	2,355	2,118	2,828	3,439
Change	-	99.15%	-26.84%	-16.96%	5.06%	-10.09%	33.54%	21.61%
Net income ¹	1,414	2,804	2,050	1,663	1,714	1,682	2,121	2,579
Change	-	98.31%	-26.88%	-18.89%	3.07%	-1.9%	26.13%	21.59%
Announcement Date	15/05/20	15/05/21	09/05/22	29/04/23	03/05/24	06/05/25	-	-

¹INR in Million

Estimates

Fiscal Period: March	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1
Net sales ¹	4,054	4,775	4,735	4,496	5,447	5,781	5,302	5,018	5,800	5,796	6,348	6,943	6,220	6,877	6,640	7,424	6,611
Change	-	17.78%	-0.84%	-5.04%	21.13%	6.14%	-8.28%	-5.37%	15.59%	-0.06%	9.52%	9.37%	-10.42%	10.57%	-3.45%	11.82%	-10.95%
EBITDA	547.1	683.1	674.9	713.2	1,340	1,164	1,058	809.3	796.9	737.4	900	860	671.3	742.7	-	-	-
Change	-	24.86%	-1.2%	5.67%	87.84%	-13.09%	-9.17%	-23.48%	-1.53%	-7.47%	22.05%	-4.44%	-21.94%	10.64%	-	-	-
EBIT	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Charge d'intérêts	-93.3	-85.4	-83.9	-74.7	-65.7	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT)	336.3	478.7	430.8	607.2	1,163	971.2	-	-	-	-	-	-	-	-	-	-	-
Change	-	42.34%	-10.01%	40.95%	91.5%	-16.48%	-	-	-	-	-	-	-	-	-	-	-
Net income	224.5	323.1	277.8	588.6	854.5	752.7	680.3	516.5	488.1	425.8	-	553.4	347.9	387.5	-	-	-
Change	-	43.92%	-14.01%	111.86%	45.17%	-11.91%	-9.62%	-24.08%	-5.5%	-12.76%	-	-	-37.13%	11.38%	-	-	-
Announcement Date	26/07/19	23/10/19	06/02/20	15/05/20	25/07/20	23/10/20	25/01/21	15/05/21	27/07/21	27/10/21	31/01/22	09/05/22	27/07/22	20/10/22	27/01/23	29/04/23	21/07/23

¹INR in Million

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	15/05/20	15/05/21	09/05/22	29/04/23	03/05/24	06/05/25	-	-

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	479.9	881.3	1,437	1,647	2,263	1,772	1,500	1,500
Change	-	83.64%	63.03%	14.61%	37.44%	-21.72%	-25%	0%
Free Cash Flow (FCF) ¹	2,028	667.2	-740.4	-304.7	1,326	674.2	1,023	1,149
Change	-	-67.09%	-210.97%	58.85%	535.15%	-49.15%	-12.64%	12.32%
Announcement Date	15/05/20	15/05/21	09/05/22	29/04/23	03/05/24	06/05/25	-	-

¹INR in Million

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	14.5%	20.29%	13.24%	11.25%	12.52%	12.03%	13.9%	14.5%
EBIT Margin (%)	-	17.97%	11.23%	9.4%	10.48%	9.69%	11.62%	12.29%
EBT Margin (%)	10.26%	17.13%	10.85%	8.25%	9.31%	8.87%	10.52%	11.36%
Net margin (%)	7.83%	13.01%	8.24%	6.12%	6.78%	7.04%	7.89%	8.52%
FCF margin (%)	11.23%	3.1%	-2.98%	-1.12%	5.24%	2.82%	3.81%	3.8%
FCF / Net Income (%)	143.39%	23.79%	-36.11%	-18.32%	77.35%	40.09%	48.23%	44.55%
Profitability
ROA	9.1%	-	10.32%	-	-	-	-	-
ROE	23.08%	35.81%	21.03%	14.92%	13.86%	12.69%	14.6%	15.9%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	2.66%	4.09%	5.77%	6.06%	8.95%	7.42%	5.58%	4.96%
CAPEX / EBITDA (%)	18.33%	20.16%	43.61%	53.88%	71.52%	61.72%	40.14%	34.18%
CAPEX / FCF (%)	23.67%	132.09%	-194.06%	-540.43%	170.7%	262.77%	146.63%	130.55%
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	0.5	2.5	1	-	1	0.8	5.8	7.1
Change	-	400%	-60%	-	-	-20%	625%	22.41%
Book Value Per Share ¹	69.88	98.01	111.9	128.8	139.4	150	167.4	188.6
Change	-	40.26%	14.19%	15.06%	8.25%	7.61%	12.65%	12.66%
EPS ¹	15.14	30.09	22.12	17.97	18.56	18.35	23.2	28.3
Change	-	98.71%	-26.49%	-18.76%	3.28%	-1.13%	49.68%	21.98%
Nbr of stocks (in thousands)	93,200	93,200	92,600	92,600	91,935	91,935	91,935	91,935
Announcement Date	15/05/20	15/05/21	09/05/22	29/04/23	03/05/24	06/05/25	-	-